Clinical Trials on Antinociceptive Agents in Belgium

Total 25 results

Erasme University Hospital

Recruiting

Management of Neuromuscular Blocking Agents and Their Antagonism (NMBA_periop)

Neuromuscular Monitoring | Neuromuscular Blocking Agents

Belgium
Jules Bordet Institute
Université Libre de Bruxelles; Fondation Kisane; Les Amis de l'Institut

Unknown

A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting (MADESIO)

Adults | Hematological Malignancy | Oral Antineoplastic Agents

Belgium
The University of Queensland

Unknown

Screening Anti-Fungal Exposure in Intensive Care Units (SAFE-ICU)

Antifungal Agents

Belgium, Spain, Finland, United States, Australia, Canada, France, Greece, Hong Kong, Italy, Malaysia, Netherlands, Portugal
Universitaire Ziekenhuizen KU Leuven

Completed

Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports

Blood Transfusion Events

Belgium
University Ghent
Research Foundation Flanders; Flemish Agency for Care and Health

Completed

Promoting Healthy Lifestyle Behaviors in Schoolchildren: an Online Video Intervention for Parents (Movie Models)

Physical Activity | Parenting | Parents | Sedentary Behavior | Healthy Diet | Primary Schoolchildren

Belgium
Université Libre de Bruxelles

Completed

The Influence of Parental Behavior on the Course of the Pediatric Dentistry Session

Parents | Dental Anxiety | Behavior, Child

Belgium
University Hospital, Ghent

Completed

Cluster-RCT Collective Nasopharyngeal COVID-19 Testing Amongst Pupils

Parents | Peer Group

Belgium
Université Catholique de Louvain

Recruiting

Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units (Pop-PK/PD)

Pharmacokinetics | Infection | Infection, Bacterial | Anti-Bacterial Agents | Drug Monitoring | Infections, Respiratory

Belgium
Paul M. Tulkens

Recruiting

Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients (TEMODELTA)

Pharmacokinetics | Infection | Infections, Bacterial | Drug Monitoring | Antibacterial Agents | Temocillin

Belgium
Universitair Ziekenhuis Brussel
University Ghent; Vrije Universiteit Brussel

Not yet recruiting

Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. (PABTOX)

Breast Cancer | Body Weight | Chemotherapeutic Toxicity | Physical Inactivity | Chemotherapeutic Agent Toxicity | Paclitaxel Adverse Reaction

Belgium
Université Catholique de Louvain

Completed

Plasmapheresis: a Multi-modal Approach

Inflammation | Body Composition | Immunology | Adverse Events | Plasmapheresis | Sport Performance | Haematology

Belgium
Erasme University Hospital
Ipsen; Fonds National de la Recherche Scientifique

Completed

Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure (Erasme-POF)

Lymphoma | Fertility Preservation | Alkylating Agents

Belgium, France, Italy
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

Immunotherapy | Pneumonitis, Interstitial | Immune-related Adverse Events

Belgium
ThromboGenics
BioInvent International AB

Completed

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Prophylaxis of Venous Thromboembolic Events

Austria, Netherlands, Belgium, Bulgaria, Hungary, Latvia, Poland, Russian Federation, Ukraine
Prof. dr. Filip Raes
Research Foundation Flanders

Completed

Recalling and Anticipating Specific Positive Events to Boost Resilience in Adolescents (RASPERA)

Resilience | Mental Wellbeing | Specific Positive Memories | Specific Positive Future Events

Belgium
University Hospital, Ghent
Algemeen Ziekenhuis Maria Middelares; Onze Lieve Vrouwziekenhuis Aalst; AZ Jan... and other collaborators

Recruiting

Move ARound And Get Active: an Intervention to Optimize 24-hour Movement Behaviours in Preschoolers (MARGA)

Sleep | Parenting | Parents | Child Behavior | Sedentary Behavior | Sedentary Time | Child Obesity | Physical Inactivity

Belgium
European Organisation for Research and Treatment...

Terminated

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Head and Neck Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

Spain, France, Belgium, Italy, United Kingdom, Turkey
R&D Cardiologie

Completed

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) (WOEST)

Atrial Fibrillation | Stents | Anticoagulants | Platelet Aggregation Inhibitors

Netherlands, Belgium
Abbott Medical Devices

Completed

Lead Registry for Optim Leads (OPTIMUM)

Optim Lead Insulation Related Adverse Events

United States, Belgium, Germany
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Pfizer

Terminated

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Locally Advanced or Metastatic Solid Tumors | Genes, BRCA 1

United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (CYCLONE 3)

Urogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditions

China, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
AstraZeneca

Terminated

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events (EXTEND)

Thromboembolism

Sweden, France, Mexico, Poland, South Africa, Spain, Germany, Hungary, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Switzerland
Novartis Pharmaceuticals

Terminated

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People (APOLLO)

Cardiovascular Events

Colombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
Bayer

Completed

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis (CONVERT)

Hemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic Events

Spain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal

Clinical Trials on Antinociceptive Agents in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations